Update on medical management of atrial fibrillation in the modern era

Rakesh Gopinathannair1, Renee M Sullivan, Brian Olshansky

  • 1Division of Cardiovascular Medicine, University of Iowa Hospitals, Iowa City, Iowa 52242, USA.

Heart Rhythm
|June 24, 2009
PubMed

Insights

This review details the current medical management of atrial fibrillation, focusing on rate control, anticoagulation for stroke prevention, and rhythm control. It highlights the expanding therapeutic landscape for atrial fibrillation treatment.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Atrial fibrillation management requires controlling heart rate, preventing stroke with anticoagulation, and maintaining sinus rhythm.
  • Therapeutic options for atrial fibrillation are expanding, increasing treatment complexity.
  • Key goals of atrial fibrillation treatment include symptom improvement, reducing adverse outcomes, and enhancing survival.

Purpose of the Study:

  • To provide an updated review of the state-of-the-art medical management of atrial fibrillation.
  • To incorporate present and emerging evidence into the understanding of atrial fibrillation treatment.

Main Methods:

  • Literature review of current and emerging evidence on atrial fibrillation management.
  • Focus on pharmacological interventions as the primary treatment modality.

Main Results:

  • Medical management remains the cornerstone of atrial fibrillation treatment.
  • Expanding therapeutic options necessitate a complex approach to patient care.
  • Non-pharmacological approaches are gaining interest but drugs are primary.

Conclusions:

  • The medical management of atrial fibrillation is evolving with new evidence.
  • Pharmacological treatments are central to managing atrial fibrillation symptoms and outcomes.
  • A comprehensive approach is needed to optimize care for patients with atrial fibrillation.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...